Kurt Sheline

Kurt Sheline supports Echo Health Ventures in all aspects of the investment process, from deal sourcing and evaluation through transaction management and execution. He is responsible for providing financial and market support that drives investment initiatives and decisions, and the success and growth of Echo’s portfolio of companies.

Kurt currently serves as a director on the board of Springbuk and Eleanor Health. He is a board observer for Octave Bioscience, GNS Healthcare, and Circulation.

Before joining Echo Health Ventures in 2017, Kurt was a Vice President in Cascadia Capital’s Healthcare Technology and Services group, based in Seattle, where he worked closely with management teams in the life sciences, healthcare technology, and health care services industries, providing business development, positioning, sales & marketing, and transaction advisory and execution services.

Kurt earned an MBA from the University of California, Berkeley, and a bachelor’s degree, magna cum laude, in Economics/Pre-Medical Studies from Claremont McKenna College. He lives with his wife, two daughters, and Goldendoodle in Seattle, and enjoys golf, boating, craft beer, and a budding interest in mountaineering.